Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer

Despite their efficacy, uptake of selective estrogen receptor modulators for breast cancer chemoprevention remains low. Exemestane, an aromatase inhibitor, has recently been identified as a potential chemopreventive option with fewer serious side effects compared with selective estrogen receptor mod...

Full description

Bibliographic Details
Main Authors: Aktas, Bilge, Sorkin, Mia, Pusztai, Lajos, Hofstatter, Erin W.
Format: Online
Language:English
Published: Lippincott Williams & Wilkins 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885537/